Michael G. O’Connor

605 total citations
23 papers, 315 citations indexed

About

Michael G. O’Connor is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Michael G. O’Connor has authored 23 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Michael G. O’Connor's work include Neonatal Respiratory Health Research (11 papers), Cystic Fibrosis Research Advances (9 papers) and Asthma and respiratory diseases (5 papers). Michael G. O’Connor is often cited by papers focused on Neonatal Respiratory Health Research (11 papers), Cystic Fibrosis Research Advances (9 papers) and Asthma and respiratory diseases (5 papers). Michael G. O’Connor collaborates with scholars based in United States, Canada and Germany. Michael G. O’Connor's co-authors include Adam J. Shapiro, Amjad Horani, Margaret W. Leigh, Donald H. Arnold, Adam C. Seegmiller, Maimoona A. Zariwala, Michael R. Knowles, Sharon Dell, Milan J. Hazucha and Nadzeya Marozkina and has published in prestigious journals such as PEDIATRICS, The Journal of Pediatrics and European Journal of Pharmacology.

In The Last Decade

Michael G. O’Connor

22 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael G. O’Connor United States 11 219 60 56 51 45 23 315
N. Desmazes-Dufeu France 10 282 1.3× 48 0.8× 52 0.9× 34 0.7× 102 2.3× 21 423
Marina Coletta Italy 10 68 0.3× 86 1.4× 47 0.8× 127 2.5× 221 4.9× 23 393
Anita M. Van den Neucker Netherlands 8 69 0.3× 68 1.1× 22 0.4× 46 0.9× 143 3.2× 11 332
P Boutté France 8 45 0.2× 50 0.8× 20 0.4× 32 0.6× 33 0.7× 49 219
Konstantinos Argyriou Greece 8 49 0.2× 59 1.0× 17 0.3× 67 1.3× 85 1.9× 28 267
Cristina Panetta Italy 8 70 0.3× 32 0.5× 33 0.6× 11 0.2× 129 2.9× 17 318
Jonathan McCormick United Kingdom 11 552 2.5× 139 2.3× 20 0.4× 29 0.6× 50 1.1× 13 628
İlker Turan Türkiye 10 54 0.2× 42 0.7× 26 0.5× 19 0.4× 111 2.5× 38 235
Khadija Nuzhat Humayun Pakistan 11 42 0.2× 45 0.8× 47 0.8× 92 1.8× 54 1.2× 34 317
C H Skeoch United Kingdom 10 77 0.4× 30 0.5× 16 0.3× 122 2.4× 38 0.8× 16 306

Countries citing papers authored by Michael G. O’Connor

Since Specialization
Citations

This map shows the geographic impact of Michael G. O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. O’Connor more than expected).

Fields of papers citing papers by Michael G. O’Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. O’Connor. The network helps show where Michael G. O’Connor may publish in the future.

Co-authorship network of co-authors of Michael G. O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. O’Connor. A scholar is included among the top collaborators of Michael G. O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. O’Connor. Michael G. O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shapiro, Adam J., Eveline Y. Wu, Déborah Morris-Rosendahl, et al.. (2025). Overlapping Clinical Phenotypes in Patients with Primary Ciliary Dyskinesia or Activated Phosphoinositide 3-Kinase Delta Syndrome. The Journal of Pediatrics. 280. 114499–114499. 1 indexed citations
2.
Moore, Paul E., et al.. (2024). The utility of nasal nitric oxide in the diagnostic evaluation of primary ciliary dyskinesia. Pediatric Pulmonology. 59(5). 1410–1417. 1 indexed citations
3.
4.
Reasoner, Seth A., Kyle T. Enriquez, Benjamin Abelson, et al.. (2021). Urinary tract infections in cystic fibrosis patients. Journal of Cystic Fibrosis. 21(1). e1–e4. 3 indexed citations
5.
O’Connor, Michael G., Amjad Horani, & Adam J. Shapiro. (2021). Progress in Diagnosing Primary Ciliary Dyskinesia: The North American Perspective. Diagnostics. 11(7). 1278–1278. 26 indexed citations
6.
Leigh, Margaret W., et al.. (2019). Primary ciliary dyskinesia (PCD): A genetic disorder of motile cilia. PubMed. 4(1-2). 51–75. 57 indexed citations
7.
Shapiro, Adam J., Sharon Dell, Benjamin Gaston, et al.. (2019). Nasal Nitric Oxide Measurement in Primary Ciliary Dyskinesia. A Technical Paper on Standardized Testing Protocols. Annals of the American Thoracic Society. 17(2). e1–e12. 62 indexed citations
8.
Arnold, Donald H., et al.. (2018). Initiative to Reduce Chest X-ray Use for Pediatric Patients with Acute Asthma Exacerbations. 147–147. 1 indexed citations
9.
Johnson, David, et al.. (2018). Implementation and Improvement of Pediatric Asthma Guideline Improves Hospital-Based Care. PEDIATRICS. 141(2). 24 indexed citations
10.
Arnold, Donald H., et al.. (2018). Successful Chest Radiograph Reduction by Using Quality Improvement Methodology for Children With Asthma. PEDIATRICS. 142(2). 12 indexed citations
11.
O’Connor, Michael G., James C. Slaughter, Nathalie L. Maitre, et al.. (2017). Pulmonary hypertension in the premature infant population: Analysis of echocardiographic findings and biomarkers. Pediatric Pulmonology. 53(3). 302–309. 15 indexed citations
12.
Qayed, Muna, Dawn M. Simon, Thomas F. Cash, et al.. (2017). Respiratory Difficulties in Children With Underlying Asthma During Immunotherapy for High-risk Neuroblastoma. Journal of Pediatric Hematology/Oncology. 39(8). e450–e453. 2 indexed citations
13.
O’Connor, Michael G. & Adam C. Seegmiller. (2016). The effects of ivacaftor on CF fatty acid metabolism: An analysis from the GOAL study. Journal of Cystic Fibrosis. 16(1). 132–138. 20 indexed citations
14.
O’Connor, Michael G., et al.. (2016). Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study. Prostaglandins Leukotrienes and Essential Fatty Acids. 113. 46–49. 7 indexed citations
15.
O’Connor, Michael G., David N. Cornfield, & Eric D. Austin. (2016). Pulmonary hypertension in the premature infant. Current Opinion in Pediatrics. 28(3). 324–330. 14 indexed citations
16.
O’Connor, Michael G., Benjamin R. Saville, Tina V. Hartert, & Donald H. Arnold. (2014). Treatment Variability of Asthma Exacerbations in a Pediatric Emergency Department Using a Severity-Based Management Protocol. Clinical Pediatrics. 53(13). 1288–1290. 15 indexed citations
17.
18.
Mangus, Richard S., Michael G. O’Connor, A. Joseph Tector, Joel Lim, & Rodrigo Vianna. (2010). Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut. Journal of Pediatric Surgery. 45(6). 1266–1273. 14 indexed citations
19.
Mattson, David L. & Michael G. O’Connor. (1986). Transilluminator assistance in neonatal venipuncture.. PubMed. 5(1). 42–5. 1 indexed citations
20.
Buckner, Carl K., Jay E. Birnbaum, & Michael G. O’Connor. (1974). Factors influencing observed β-adrenergic receptor antagonism in guinea-pig trachea. European Journal of Pharmacology. 26(2). 198–203. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Desmazes-Dufeu Breakdown of academic impact, for papers by Marina Coletta Breakdown of academic impact, for papers by Anita M. Van den Neucker Breakdown of academic impact, for papers by P Boutté Breakdown of academic impact, for papers by Konstantinos Argyriou Breakdown of academic impact, for papers by Cristina Panetta Breakdown of academic impact, for papers by Jonathan McCormick Breakdown of academic impact, for papers by İlker Turan Breakdown of academic impact, for papers by Khadija Nuzhat Humayun Breakdown of academic impact, for papers by C H Skeoch
Rankless by CCL
2026